PCM
CLLS

Penserra Capital Management’s Cellectis CLLS Stock Holding History

Penserra Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-475
Closed -$5K – 1400
2021
Q3 		$5K Buy
475
+45
+10% +$623 ﹤0.01% 1405
2021
Q2 		$6K Sell
430
-5
-1% -$84 ﹤0.01% 1308
2021
Q1 		$8K Buy
435
+25
+6% +$618 ﹤0.01% 1056
2020
Q4 		$11K Buy
410
+256
+166% +$5.74K ﹤0.01% 913
2020
Q3 		$2K Buy
+154
New +$2.73K ﹤0.01% 904

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Penserra Capital Management's CLLS Position: Q4 2021 in Review

Penserra Capital Management sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 475 shares — an estimated $5K sold.

Penserra Capital Management first reported a position in CLLS in Q3 2020 and held it in 5 quarters. The position peaked at $11K in Q4 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Penserra Capital Management reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Penserra Capital Management sold 475 Cellectis shares in Q4 2021, an estimated $5K.
  • Penserra Capital Management first reported a position in Cellectis in Q3 2020 and held it in 5 quarters.
  • Penserra Capital Management's Cellectis position peaked at $11K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.